Director Myra Biblowit (NYSE: WH) receives 294 shares on vesting

Rhea-AI Filing Summary

Wyndham Hotels & Resorts director Myra J. Biblowit acquired 294 shares of common stock through equity compensation. The shares were delivered at no cost on March 3, 2026, when previously granted restricted stock units vested under the company’s 2018 Equity and Incentive Plan.

After this vesting, she directly holds 14,764 shares of common stock. The filing also updates her balances in deferred stock units and restricted stock units, which are additional forms of stock-based compensation rather than open‑market trades.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BIBLOWIT MYRA J

(Last) (First) (Middle)

WYNDHAM HOTELS & RESORTS, INC.

22 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WYNDHAM HOTELS & RESORTS, INC. [ WH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		294(1)	A	$0	14,764(2)	D
Common Stock								91,922(3)	D
Common Stock								2,405(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Common stock acquired under the Issuer's 2018 Equity and Incentive Plan on vesting of previously-granted restricted stock units which vested on March 3, 2026.

2. Represents shares of common stock.

3. Represents deferred stock units.

4. Represents restricted stock units.

Remarks:

	/s/ Paul F. Cash as Attorney-in-Fact for Myra J. Biblowit	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did WH director Myra J. Biblowit report?

Myra J. Biblowit reported acquiring 294 shares of Wyndham common stock. The shares were issued at no cost when previously granted restricted stock units vested under the 2018 Equity and Incentive Plan on March 3, 2026, reflecting routine equity compensation.

How many Wyndham (WH) shares does Myra J. Biblowit hold after this Form 4?

After the transaction, Myra J. Biblowit directly holds 14,764 shares of Wyndham common stock. This total reflects the addition of 294 shares received upon vesting of restricted stock units granted under the company’s 2018 Equity and Incentive Plan.

Was cash paid for the 294 Wyndham (WH) shares reported in this Form 4?

No cash was paid for the 294 shares. They were issued at a price of $0.00 per share when previously granted restricted stock units vested on March 3, 2026, under Wyndham’s 2018 Equity and Incentive Plan as part of director compensation.

What is the source of the shares Myra J. Biblowit acquired in Wyndham (WH)?

The 294 shares came from vesting of restricted stock units previously granted to Myra J. Biblowit. These units vested on March 3, 2026, under Wyndham Hotels & Resorts’ 2018 Equity and Incentive Plan, converting into common stock as part of her equity compensation.

Does the Wyndham (WH) Form 4 show open-market buying or selling by Myra J. Biblowit?

The filing does not show open-market buying or selling. It records a grant, award, or other acquisition of 294 common shares at $0.00 per share due to vesting of restricted stock units, along with updated balances in deferred and restricted stock units.